From the Division of Epidemiology (M.K.H., S.C.R., X.S., H.Q., D.Q., L.F.B.), School of Public Health, University of California, Berkeley; Computational Biology Graduate Group (M.K.H., L.F.B.), University of California, Berkeley; Kaiser Permanente Division of Research (V.C., K.H.B., P.D., J.M., T.C., T.J.M., C.A.S., L.F.B.), Oakland, CA; The Permanente Medical Group (N.B.), Walnut Creek, CA; The Permanente Medical Group (J.F.M.), San Francisco, CA; and Departments of Pediatrics and Neurology (E.W.), University of California, San Francisco.
Neurology. 2023 Mar 28;100(13):e1353-e1362. doi: 10.1212/WNL.0000000000206791. Epub 2023 Jan 11.
Migraine is common among people with multiple sclerosis (MS), but the reasons for this are unknown. We tested 3 hypothesized mechanisms for this observed comorbidity, including migraine is a risk factor of MS, genetic variants are shared between the conditions, and migraine is because of MS.
Data were from 2 sources: publicly available summary statistics from genome-wide association studies of MS (N = 115,748) and migraine (N = 375,752 and N = 361,141) and a case-control study of MS recruited from the Kaiser Permanente Northern California Health Plan (N = 1,991). For the latter participants, migraine status was ascertained using a validated electronic health record migraine probability algorithm or self-report. Using the public summary statistics, we used 2-sample Mendelian randomization to test whether a migraine genetic instrumental variable was associated with MS. We used linkage disequilibrium score regression and LOGODetect to ascertain whether MS and migraine shared genetic variants across the genome and regionally. Using the Northern California MS cohort, we used logistic regression to identify whether people with both MS and migraine had different odds of clinical characteristics (e.g., age at MS onset, Perceived Deficits Questionnaire, and depression) or MS-specific risk factors (e.g., body mass index, smoking status, and infectious mononucleosis status) compared with people with MS without migraine.
We did not find evidence supporting migraine as a causal risk factor of MS ( = 0.29). We did, however, identify 4 major histocompatibility complex (MHC) loci shared between MS and migraine. Among the Northern California MS cohort, 774 (39%) experienced migraine. People with both MS and migraine from this cohort were more likely to ever smoke (odds ratio [OR] = 1.30, 95% CI: 1.08-1.57), have worse self-reported cognitive deficits (OR = 1.04, 95% CI: 1.02-1.06), and ever experience depression (OR = 1.48, 95% CI: 1.22-1.80).
Our findings do not support migraine as a causal risk factor of MS. Several genetic variants, particularly in the MHC, may account for some of the overlap. It seems likely that migraine within the context of MS is because of MS. Identifying what increases the risk of migraine within MS might lead to an improved treatment and quality of life.
偏头痛在多发性硬化症(MS)患者中较为常见,但原因尚不清楚。我们对三种假设机制进行了测试,以解释这种观察到的共病现象,包括偏头痛是 MS 的一个风险因素、遗传变异在这两种疾病之间是共有的、偏头痛是由 MS 引起的。
数据来自两个来源:MS 的全基因组关联研究的公开汇总统计数据(N=115748)和偏头痛(N=375752 和 N=361141)以及 Kaiser Permanente 北加利福尼亚健康计划中招募的 MS 病例对照研究(N=1991)。对于后者的参与者,使用经过验证的电子健康记录偏头痛概率算法或自我报告来确定偏头痛的状态。使用公共汇总统计数据,我们使用两样本孟德尔随机化来测试偏头痛遗传工具变量是否与 MS 相关。我们使用连锁不平衡得分回归和 LOGODetect 来确定 MS 和偏头痛是否在整个基因组和区域内共享遗传变异。使用北加利福尼亚 MS 队列,我们使用逻辑回归来确定同时患有 MS 和偏头痛的人是否与没有偏头痛的 MS 患者相比,具有不同的临床特征(例如 MS 发病年龄、感知缺陷问卷和抑郁)或 MS 特定的风险因素(例如体重指数、吸烟状态和传染性单核细胞增多症状态)的几率。
我们没有发现支持偏头痛是 MS 因果风险因素的证据(β=0.29)。然而,我们确实确定了 MS 和偏头痛之间存在 4 个主要组织相容性复合体(MHC)基因座。在北加利福尼亚 MS 队列中,有 774 人(39%)患有偏头痛。该队列中同时患有 MS 和偏头痛的人更有可能曾经吸烟(优势比[OR] = 1.30,95%CI:1.08-1.57),自我报告的认知缺陷更严重(OR = 1.04,95%CI:1.02-1.06),并且更有可能曾经经历过抑郁(OR = 1.48,95%CI:1.22-1.80)。
我们的研究结果不支持偏头痛是 MS 的因果风险因素。一些遗传变异,特别是 MHC 中的遗传变异,可能是两种疾病重叠的部分原因。MS 患者中的偏头痛似乎很可能是由 MS 引起的。确定在 MS 中增加偏头痛风险的因素可能会导致治疗和生活质量的改善。